Tata to shift focus to diabetes

The Tata Group, one of the largest companies in India, are now expanding their focus to include diabetes research and development. The group has reportedly made significant advancement in the fields of diabetes and metabolic disorder.
Top executives at Tata Industries said that research is ongoing, and the company are examining potential treatments for diabetes . However, Tata have made it clear that they will not start to manufacture pharmaceuticals . Their focus will be on pharma technology.
The company have not yet fixed a budget or milestones for their diabetes treatment development. Tata made history earlier this year by releasing the world’s smallest car, the Nano, to the Indian market.